Axiomedix, Inc.
Bedford
About Axiomedix, Inc.
Axiomedix is an innovative health technology leader, renowned for supporting the i2b2 and tranSMART platforms for pharmaceutical companies, hospitals, medical centers, and universities. We are now launching the Connect+ Health Data Ecosystem (connectplus.health), a new marketplace transforming healthcare collaboration globally. This secure and ethical platform connects diverse health data suppliers with data consumers, fostering innovation, enhancing patient outcomes, and driving health equity on a global basis. With a focus on ethical data sourcing and increasing access to diverse datasets for ethical AI, Connect+ is an unparalleled opportunity for investors to lead healthcare transformation. #Axiomedix #HealthTech #DataDiversity #HealthEquity #Innovation #InvestInHealthTech
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $200.0K
- Funding stage: Seed
- Last round: Pre-Seed (Jun 2018)
- Website: axiomedix.com
- Phone: 9786529260
Industries & Categories
Health Care, Information Technology, Software
Social Profiles
Canonical: https://fsome.com/organization/axiomedix-inc-28802 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.